Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tariquidar in chemotherapy resistant advanced breast cancer
NCT00048633Phase 2Completed
- Sponsor
- QLT Inc.
- Start
- Nov 2001
- Primary completion
- Jun 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tariquidar in breast cancer, sponsored by QLT Inc.. Started Nov 2001; status: completed.
02
Drugs
tariquidar
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00048633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00048633.